Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 9:12 PM
Ignite Modification Date:
2025-12-24 @ 9:12 PM
NCT ID:
NCT06549504
Eligibility Criteria:
Inclusion Criteria:
* Subjects aged 19 years or older at the time of screening
* Subjects with a BMI of 18.0-30.0 kg/m2
* Subjects who do not have clinically significant congenital or chronic diseases and who do not have any pathological symptoms or findings as a result of general clinical examination
* Subjects who are deemed eligible based on the screening tests
Exclusion Criteria:
* Subjects who have taken drugs that induce or inhibit drug metabolizing enzymes within 30 days prior to the first dose or who have taken drugs that may interfere with the investigational product within 10 days prior to the first dose
* Subjects who have taken the investigational drug within 6 months prior to the first dose
* Subjects who donated whole blood within 8 weeks prior to the first dose, or donated blood components within 2 weeks, or received a blood transfusion within 4 weeks prior to the first dose
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
19 Years
Study:
NCT06549504
Study Brief:
Protocol Section:
NCT06549504